Transcutaneous carbon dioxide monitoring in ALS: Assessment of hypoventilation heats up
- PMID: 35064933
- PMCID: PMC8930532
- DOI: 10.1002/mus.27502
Transcutaneous carbon dioxide monitoring in ALS: Assessment of hypoventilation heats up
Keywords: amyotrophic lateral sclerosis; neuromuscular disorder; noninvasive ventilation; respiratory failure; transcutaneous carbon dioxide.
Conflict of interest statement
JA has served as a paid consultant for Hillrom. The remaining authors have no conflicts of interest.
Comment on
-
Transcutaneous CO2 monitoring as indication for inpatient non-invasive ventilation initiation in patients with amyotrophic lateral sclerosis.Muscle Nerve. 2022 Apr;65(4):444-447. doi: 10.1002/mus.27457. Epub 2021 Nov 23. Muscle Nerve. 2022. PMID: 34761401
References
-
- Miller R, Jackson C, Kasarskis E, England J, Forshew D, Johnston W, et al. Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology: 2009;73:1218–1226. 10.1212/wnl.0b013e3181bc0141. - DOI - PMC - PubMed
-
- Local Coverage Determination Respiratory Assist Devices L33800. https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=33800. Accessed January 5, 2022.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
